Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and ...

For those who live with schizophrenia, the sound of voices — voices that no one else can hear — can be an overwhelming and ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the ...

Beyond the known respiratory and cardiovascular risks, emerging evidence suggests that both indoor and outdoor air pollution ...

Recent clinical trials have shown that agonists of muscarinic acetylcholinergic receptors can improve both psychotic and negative symptoms in schizophrenia. Here, this new approach to the treatment of ...

I have schizoaffective disorder, bipolar type — a combination of schizophrenia and bipolar disorder — and I agree that this is a monumental development for my community. Historically ...

Shares of AbbVie (ABBV) are sliding on Monday after the company’s drug candidate for schizophrenia failed to meet the key goal in two ...

My name is Bethany Yeiser, and I am an individual living with schizophrenia. My schizophrenia has been in full remission since 2008, thanks to treatment with clozapine, the vastly underutilized ...

The risk was twice as high in people with depression, 3-fold higher among those with bipolar disorder, and 4.5 times higher risk among those with schizophrenia. Mental health disorders were also ...

Auditory verbal hallucinations are one of the hallmarks of psychosis, particularly in people with schizophrenia, which affects 24 million people globally. These voices often bully or abuse the ...

Anti-marijuana PSAs from the state have come as Gov. Ron DeSantis has ramped up his campaign against a proposed recreational ...

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Shares of AbbVie have dropped sharply ...